Epstein-Barr virus LMP2A enhances B-cell responses in vivo and in vitro
about
Epstein-Barr virus LMP2A reduces hyperactivation induced by LMP1 to restore normal B cell phenotype in transgenic miceLinking complement and anti-dsDNA antibodies in the pathogenesis of systemic lupus erythematosusEBV LMP2A provides a surrogate pre-B cell receptor signal through constitutive activation of the ERK/MAPK pathway.The viral latency-associated nuclear antigen augments the B-cell response to antigen in vivoEpstein-Barr virus LMP2A imposes sensitivity to apoptosis.Epstein-Barr virus latent membrane protein 2A exacerbates experimental autoimmune encephalomyelitis and enhances antigen presentation function.Evasion of affinity-based selection in germinal centers by Epstein-Barr virus LMP2A.Transcriptome changes induced by Epstein-Barr virus LMP1 and LMP2A in transgenic lymphocytes and lymphoma.Epstein-Barr virus latent membrane protein 2A preferentially signals through the Src family kinase LynNF-κB as a target for oncogenic viruses.Epstein-Barr virus LMP2A increases IL-10 production in mitogen-stimulated primary B-cells and B-cell lymphomas.Epstein-Barr virus LMP2A accelerates MYC-induced lymphomagenesis.Murine gammaherpesvirus M2 antigen modulates splenic B cell activation and terminal differentiation in vivo.Manipulation of the toll-like receptor 7 signaling pathway by Epstein-Barr virus.Mouse model of Epstein-Barr virus LMP1- and LMP2A-driven germinal center B-cell lymphoproliferative disease.Global Proteomic Changes Induced by the Epstein-Barr Virus Oncoproteins Latent Membrane Protein 1 and 2A.Co-Expression of the Epstein-Barr Virus-Encoded Latent Membrane Proteins and the Pathogenesis of Classic Hodgkin Lymphoma
P2860
Q27345929-4E8B782D-5E1B-42B8-907A-F071F909433CQ33599086-3D9B2682-37DA-447F-BEB8-AC05E3F197B4Q33739672-FB9CFB41-973F-4BFF-8AB8-06083C7EE9C4Q34178308-90AEA72E-DFA9-45D7-9371-3C8C555A251DQ34734755-2A889405-6261-4EFD-974A-6C7391B74ED3Q35967534-6A111BC5-82C0-4ADE-8412-995C5BEE940AQ36079038-8E2B3505-83D8-410F-AF23-1EBEA60DF471Q36250603-2461B2F0-EE26-4A60-86E4-B302ED259B27Q36845865-7820CB8E-1D22-4E47-BEE0-F043DA9F95BAQ37374081-72C72FBE-09FE-47FE-A976-FBA3DFDCE1BFQ38942281-3A75A68D-0F10-4DCE-B1DB-AEACB4E855C8Q39742944-AF1F5786-3EAF-4B83-A6FD-18C248106139Q40098067-60FD573D-DB99-4F56-8725-4A6D4225DEF5Q40112081-17DF9A57-354C-49B1-9D7D-FB7E0ADCEA92Q40269570-B800FF89-D2E6-45B7-958C-3579896B9DFBQ55314625-DD4DABCA-D1DC-4775-9007-6B7066E18A97Q58704308-13744015-5D93-4421-B63C-E65A6030BA9E
P2860
Epstein-Barr virus LMP2A enhances B-cell responses in vivo and in vitro
description
2006 nî lūn-bûn
@nan
2006 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Epstein-Barr virus LMP2A enhances B-cell responses in vivo and in vitro
@ast
Epstein-Barr virus LMP2A enhances B-cell responses in vivo and in vitro
@en
Epstein-Barr virus LMP2A enhances B-cell responses in vivo and in vitro
@nl
type
label
Epstein-Barr virus LMP2A enhances B-cell responses in vivo and in vitro
@ast
Epstein-Barr virus LMP2A enhances B-cell responses in vivo and in vitro
@en
Epstein-Barr virus LMP2A enhances B-cell responses in vivo and in vitro
@nl
prefLabel
Epstein-Barr virus LMP2A enhances B-cell responses in vivo and in vitro
@ast
Epstein-Barr virus LMP2A enhances B-cell responses in vivo and in vitro
@en
Epstein-Barr virus LMP2A enhances B-cell responses in vivo and in vitro
@nl
P2093
P2860
P356
P1433
P1476
Epstein-Barr virus LMP2A enhances B-cell responses in vivo and in vitro
@en
P2093
Michelle Swanson-Mungerson
Rebecca Bultema
Richard Longnecker
P2860
P304
P356
10.1128/JVI.00433-06
P407
P577
2006-07-01T00:00:00Z